Mavacamten Real-World Safety: a post-authorisation multi-national, long-term, observational study in patients with obstructive Hypertrophic Cardiomyopathy (oHCM) in the real-world setting in Europe (CV027-013)

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  Register of Hypertrophic Cardiomyopathy (REMY) France, Translational Registry for Cardiomyopathies (TORCH) Germany, Statutory Health Insurance (SHI) Claims Germany, Clinical Practice Research Datalink (CPRD) Aurum United Kingdom, Danish National Health and Socioeconomic registries Denmark
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Disease registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No